We are live on ! Find out more
DCPH

Deciphera Pharmaceuticals, Inc. Common Stock
DCPH

Delisted

DCPH was delisted on the 10th of June, 2024.

Back to rankings

85 hedge funds and large institutions have $522M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 36 increasing their positions, 17 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

112% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 17

64% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 11

6% more funds holding

Funds holding: 80 → 85 (+5)

0% more capital invested

Capital invested by funds: $522M → $522M (+$40.5K)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

96% less call options, than puts

Call options by funds: $778K | Put options by funds: $20.5M

Holders
85
Holders Change
+5
Holders Change %
+6.25%
% of All Funds
1.85%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
18
Increased
36
Reduced
17
Closed
11
Calls
$778K
Puts
$20.5M
Net Calls
-$19.7M
Net Calls Change
-$19.7M

Top Buyers

Rank Fund Capital Flow
1
RG
Redmile Group
California
+$13.9M
2
BlackRock
BlackRock
New York
+$7.3M
3
Millennium Management
Millennium Management
New York
+$4.84M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.78M
5
ACH
ArrowMark Colorado Holdings
Colorado
+$3.52M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$11.6M
2
SHI
SV Health Investors
Massachusetts
-$7.49M
3
SI
Sofinnova Investments
California
-$5.02M
4
DCM
Driehaus Capital Management
Illinois
-$3.48M
5
SFM
Sphera Funds Management
Israel
-$2.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
FI
26
Fosun International
China
$2.89M – – –
Northern Trust
27
Northern Trust
Illinois
$2.77M -$281K -12,020 -9%
Axa
28
Axa
France
$2.65M -$194K -8,278 -7%
Deutsche Bank
29
Deutsche Bank
Germany
$2.22M +$35.8K +1,531 +2%
SA
30
Sunesis Advisors
Kansas
$2.17M – – –
CIBC Asset Management
31
CIBC Asset Management
Ontario, Canada
$2.06M +$1.17M +49,884 +121%
Charles Schwab
32
Charles Schwab
California
$1.95M +$317K +13,528 +19%
AA
33
ALPS Advisors
Colorado
$1.8M +$1.87M +79,925 New
Wells Fargo
34
Wells Fargo
California
$1.47M +$1.17M +49,806 +325%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$1.32M +$265K +11,342 +24%
Fidelity Investments
36
Fidelity Investments
Massachusetts
$1.23M -$2.18M -93,211 -63%
N
37
Nuveen
North Carolina
$1.12M +$1.16M +49,708 New
Citigroup
38
Citigroup
New York
$817K +$465K +19,849 +121%
Goldman Sachs
39
Goldman Sachs
New York
$764K -$567K -24,244 -42%
Rafferty Asset Management
40
Rafferty Asset Management
New York
$689K -$58K -2,477 -7%
PPA
41
Parametric Portfolio Associates
Washington
$592K +$68.4K +2,922 +13%
AllianceBernstein
42
AllianceBernstein
Tennessee
$589K -$11.6M -496,781 -95%
Bank of America
43
Bank of America
North Carolina
$588K +$24.9K +1,062 +4%
Swiss National Bank
44
Swiss National Bank
Switzerland
$555K -$65.5K -2,800 -10%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$513K +$210K +8,972 +65%
QI
46
QS Investors
New York
$449K -$11.7K -500 -2%
EDRIA
47
Edmonds Duncan Registered Investment Advisors
Kansas
$426K – – –
OPPM
48
Opus Point Partners Management
New York
$420K – – –
Allianz Asset Management
49
Allianz Asset Management
Germany
$374K +$388K +16,591 New
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$366K +$115K +4,907 +43%
1
2
3 4

DCPH Hedge Fund Activity: Q2 2019 in Review

85 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) for Q2 2019, worth a combined $522M — up 0.01% from $522M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new DCPH positions and 11 closed out — a net gain of 7 holders — while 36 added to existing stakes and 17 trimmed.

The largest buyer was Redmile Group, adding an estimated $13.9M. The largest seller was AllianceBernstein, cutting an estimated $11.6M.

  • 85 institutional investors held Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) as of Q2 2019, up from 80 in Q1 2019.
  • Funds reported $522M of Deciphera Pharmaceuticals, Inc. Common Stock stock for Q2 2019, up 0.01% quarter-over-quarter.
  • 18 funds opened new Deciphera Pharmaceuticals, Inc. Common Stock positions in Q2 2019 and 11 closed out, a net change of +7 holders.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock buyer in Q2 2019 was Redmile Group, an estimated $13.9M added.
  • The largest Deciphera Pharmaceuticals, Inc. Common Stock seller in Q2 2019 was AllianceBernstein, an estimated $11.6M sold.

Based on aggregated 13F filings for Q2 2019.